Marta Weinstock-Rosin

**Marta Weinstock-Rosin** (an haife ta a shekara ta 1935; Ibrananci) masanin ilimin jijiyoyin jiki ne na Isra'ila ne wanda aka haifa a ƙasar Austriya, wanda aka fi sani da mai haɓaka rivastigmine (Exelon).

## Rayuwa ta farko da ilimi
An haifi Weinstock-Rosin a Vienna. Bayan an kama mahaifinta saboda kasancewa Bayahude, iyalin suka tsere daga Austria zuwa Ingila a 1939, jim kadan kafin yakin. Kwanakin da ta fara a Ingila sun kasance da wahala. An kama mahaifinta a matsayin ɗan ƙasa na ƙasar abokan gaba, kuma mahaifiyarta ba ta da ƙwarewa kuma ba ta magana da Turanci. Abinci ƙalubale ne don samun kuma yawancin lokacinta an ciyar da ita a cikin mafaka na iska. A lokacin da take da shekaru 12 ta nemi kalmar "pharmacologist" a cikin wani encyclopedia kuma ta yanke shawarar cewa bincike, ci gaban magani da ilmin sunadarai za su zama aikinta. Dole ne ta yi yaƙi da tsarin don samun nasara. Dole ne ta je aji na yara maza don nazarin kimiyyar lissafi, saboda ba a ba da ita a makarantar 'yan mata ba; Har ila yau, mahaifinta bai amince da shirye-shiryen likitancinta ba, saboda yana jin tsoron ba za ta taba yin aure ba. Ta sami PharmD da MS a fannin ilimin likitanci daga Jami'ar London, sannan ta sami Ph.D. a fannin likitanci na St. Mary's Hospital Medical School.

## Ayyuka
Ta ba da lacca a Jami'ar London, amma ta ji cewa a matsayin mace ta Orthodox ta Yahudawa tare da yara ta fuskanci nuna bambanci daga al'ummar ilimi ta Ingila kuma tana da iyakantaccen damar aiki. Lokacin da aka wuce ta don gabatarwa an gaya mata: "Ba ku da ɗaya daga cikinmu. Ba ku ci tare da mu kuma ba ku taɓa zuwa bukukuwan Kirsimeti ba. " [1] Wannan ya haifar da ƙaura zuwa Isra'ila a shekarar 1969, ta shiga bangaren koyarwa a Jami'ar Tel Aviv, kuma daga baya zuwa Jami'ar Ibrananci. Ta zama farfesa a Jami'ar Ibrananci a 1981 kuma shugabar Makarantar Pharmacy a 1983. [2]

Yayinda yake nazarin raguwar ƙoƙarin numfashi wanda morphine ya haifar (wanda ke rage matakin acetylcholine na kwakwalwa), Weinstock-Rosin ya sami ta hanyar "mahimmanci mai ban mamaki" magani, rivastigmine, wanda ya kara matakan acetylcholin a cikin Lobes ci gaba. Ba da daɗewa ba ta fahimci wannan magani, wanda aka samo daga physostigmine,  wanda aka samo ta hanyar haɗari,  na iya taimakawa ga Cutar Alzheimer, wanda ke da takamaiman raguwar acetylcholine a wannan yankin. An sayar da miyagun ƙwayoyi ga Sandoz, yanzu wani ɓangare na Novartis. Ta yi ƙoƙari ta jawo hankalin Teva, babban mai yin miyagun ƙwayoyi na Isra'ila a lokacin, amma ba su da sha'awar. An ba Weinstock-Rosin da jami'ar "kyakkyawan sarauta". Asalin maganin an ɓoye shi, saboda takunkumin Larabawa, kuma har zuwa 1997 ne Weinstock- Rosin ta sami karbuwa saboda bincikenta. An haɓaka shi  kuma an ba da izini a cikin 1985 kuma ya shiga amfani da magani a matsayin Exelon a cikin 1997.  Ana amfani da capsules na Rivastigmine, maganin ruwa da patches don maganin Rashin hankali mai sauƙi zuwa matsakaici na nau'in Alzheimer, kuma a Burtaniya don rashin hankali na Parkinson mai sauƙi zuwa mai matsakaici. Magungunan suna jinkirta raguwar fahimta kuma suna inganta ƙwaƙwalwar ajiya a cikin marasa lafiya da abin ya shafa. Novartis ne ya sayar da miyagun ƙwayoyi tare da tallace-tallace na shekara-shekara na dala biliyan 1.   Bayan bunkasa rivastigmine, bincikenta ya juya zuwa neman maganin rigakafi ga cutar Alzheimer.

Weinstock-Rosin ta lashe Kyautar Isra'ila ta 2014 don Magunguna saboda bincikenta na rivastigmine .  Ita farfesa ce mai daraja a Makarantar Magunguna ta Jami'ar Ibrananci . 

## Na Mutum
Weinstock-Rosin Bayahude ne na Orthodox . Ta auri Arnold Rosin, masanin ilimi tsofaffi, a cikin 1960; suna da 'ya'ya hudu da jikoki 20. 

## Manazarta